3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
2
Stomach Neoplasms
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Emergence Delirium
1
Delirium
1
Colorectal Neoplasms
1
Cachexia
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
6
Nivolumab
3
Gemcitabine
3
Cisplatin
3
Carboplatin
3
brigimadlin
2
Ramucirumab
2
Fluorouracil
2
Docetaxel
2
Cetuximab
2
tucatinib
1
trifluridine tipiracil drug combination
1
tremelimumab
1
trametinib
1
regorafenib
1
pertuzumab
1
milademetan
1
larotrectinib
1
futibatinib
1
durvalumab
1
cemiplimab
1
adagrasib
1
Trastuzumab
1
TAS-116
1
Ritonavir
1
Pemetrexed
1
Paclitaxel
1
Oxaliplatin
1
Omacor
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
Ibuprofen
×
Thoracic
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled